跳至主要内容
临床试验/NCT03601676
NCT03601676已完成不适用

Increasing Safe Outpatient Care for Emergency Department Patients With Acute Pulmonary Embolism: a Pragmatic Trial

Kaiser Permanente28 个研究点 分布在 1 个国家目标入组 1,703 人开始时间: 2015年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,703
试验地点
28
主要终点
Rate of home discharge from the emergency department following treatment for pulmonary embolism

研究概览

简要总结

To evaluate the impact of an integrated electronic clinical decision support system to facilitate risk stratification and site-of-care decision-making for patients with acute pulmonary embolism.

详细描述

Many low-risk emergency department patients with acute pulmonary embolism are routinely hospitalized despite being eligible for outpatient care. One impediment to home discharge is the difficulty of identifying which patients can safely forego hospitalization. This pragmatic clinical trial intends to evaluate the effect on emergency department disposition of a multicomponent intervention, including electronic clinical decision support system access, physician education, and physician-specific audit and feedback. The hypothesis for this study is that intervention sites, when compared with concurrent control sites, will see an increase in home discharges without an increase in 5-day pulmonary embolism-related return visits or 30-day all-cause mortality.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute objectively-confirmed pulmonary embolism, diagnosed in the emergency department

排除标准

  • Comfort-care only
  • Left the ED against medical advice
  • Current PE radiologically diagnosed >12 hrs prior to arrival
  • Recent DVT or PE diagnosed within 30 days

研究组 & 干预措施

Intervention

Active Comparator

干预措施: Integration of electronic clinical decision support (Other)

Control

No Intervention

结局指标

主要结局

Rate of home discharge from the emergency department following treatment for pulmonary embolism

时间窗: 8 months post-implementation compared to 8 months pre-implementation

次要结局

  • Number of participants with major hemorrhage, recurrent venous thromboembolism, and all-cause mortality(30 days)
  • Number of participants with return visits for pulmonary embolism-related signs, symptoms, or interventions(5 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (28)

Loading locations...

相似试验

Electronic Support for Pulmonary Embolism Emergency... | 临床试验